1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Vietnam Pharmaceuticals and Healthcare Report Q4 2015

Vietnam Pharmaceuticals and Healthcare Report Q4 2015

  • October 2015
  • -
  • Business Monitor International
  • -
  • 126 pages

Includes 3 FREE quarterly updates

BMI View: The use of telecare in Vietnam's healthcare sector will grow. This will be facilitated by theincreasing use of internet services in the country as well the government's focus on leveraging telecareservices to improve healthcare access in the Vietnam areas - boding well for drugmaker commercialprospects. In addition, the need for Vietnamese hospitals to meet the significant demand for medicalservices will see healthcare providers look towards technology to enhance their operational efficiency,providing revenue earning opportunities for companies operating in the area of information andcommunication technology.

Vietnam's Pharmaceutical Risk Reward Index score for Q415 is 47.9 out of the maximum 100. The countryscored above average for some indicators and sub-indicators, including overall market expenditure, sectorvalue growth and pensionable population. Consequently, with this moderate score, Vietnam is ranked 12th(down one position since previous quarter) out of the 19 key Asia Pacific markets, level with Thailand andIndonesia.

Table Of Contents

Vietnam Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 14
Industry Forecast 16
Pharmaceutical Market Forecast 16
Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2011-2019) 18
Healthcare Market Forecast 19
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2011-2019) 21
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2011-2019) 22
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2011-2019) 23
Prescription Drug Market Forecast 24
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 26
Patented Drug Market Forecast 26
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 28
Generic Drug Market Forecast 29
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 30
OTC Medicine Forecast 31
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 33
Pharmaceutical Trade Forecast 34
Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2013-2019) 35
Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2013-2019) 36
Key Risks To BMI's Forecast Scenario 36
Macroeconomic Forecasts 37
Economic Analysis 37
Table: Economic Activity (Vietnam 2010-2019) 40
Industry Risk Reward Index 41
Asia Pacific Risk/Reward Index 41
Vietnam Risk Reward Index 47
Rewards 47
Risks 47
Market Overview 49
Industry Trends And Developments 51
Epidemiology 51
Healthcare Sector 53
Hospital Sector 56
Table: Healthcare Resources (Vietnam 2009-2014) 56
Table: Healthcare Personnel (Vietnam 2009-2014) 56
Table: Healthcare Activity (Vietnam 2009-2014) 57
Private Healthcare Sector 59
Healthcare Insurance 60
Healthcare And Pharmaceutical Reform 61
Research And Development 62
Biotechnology Sector 63
Clinical Trials 66
Regulatory Development 69
Pharmaceutical Advertising 70
Intellectual Property Issues 71
Corruption 74
Pricing Regime 75
Reimbursement Regime 80
Pricing And Reimbursement Developments 81
Competitive Landscape 83
Research-Based Industry 83
Domestic Industry 84
Foreign Industry 85
Traditional Medicines 86
Pharmaceutical Distribution 87
Pharmaceutical Retail Sector 88
Table: Key Aspects Of Good Pharmacy Practice In Developing Countries 89
Company Profile 90
DHG Pharmaceutical 90
GlaxoSmithKline 93
Merck and Co 95
Novartis 97
Pfizer 99
Sanofi 101
Traphaco Pharmaceutical 104
Vietnam OPV Pharmaceutical Co 106
Vietnam Pharmaceutical Corporation (Vinapharm) 108
Vietnam Pharmaceutical Joint Stock Company (Ampharco) 111
Vidipha Central Pharmaceutical Joint Stock Company 113
Demographic Forecast 115
Table: Population Headline Indicators (Vietnam 1990-2025) 116
Table: Key Population Ratios (Vietnam 1990-2025) 116
Table: Urban/Rural Population and Life Expectancy (Vietnam 1990-2025) 117
Table: Population By Age Group (Vietnam 1990-2025) 117
Table: Population By Age Group % (Vietnam 1990-2025) 118
Glossary 120
Methodology 122
Pharmaceutical Expenditure Forecast Model 122
Healthcare Expenditure Forecast Model 122
Notes On Methodology 123
Risk/Reward Index Methodology 124
Index Overview 125
Table: Pharmaceutical Risk/Reward Index Indicators 125
Indicator Weightings 126

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.